|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012.
|
|
2
|
Sohaib SA, Houghton SL, Meroni R, Rockall
AG, Blake P and Reznek RH: Recurrent endometrial cancer: patterns
of recurrent disease and assessment of prognosis. Clin Radiol.
62:28–34; discussion 35–36. 2007.
|
|
3
|
Robbins JR, Yechieli R, Laser B, Mahan M,
Rasool N and Elshaikh MA: Is time to recurrence after hysterectomy
predictive of survival in patients with early stage endometrial
carcinoma? Gynecol Oncol. 127:38–42. 2012.
|
|
4
|
Creutzberg CL, van Putten WL, Koper PC,
Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens
LC, van den Bergh AC, van der Steen-Banasik E, et al: PORTEC Study
Group: Survival after relapse in patients with endometrial cancer:
results from a randomized trial. Gynecol Oncol. 89:201–209.
2003.
|
|
5
|
Lin LL, Grigsby PW, Powell MA and Mutch
DG: Definitive radiotherapy in the management of isolated vaginal
recurrences of endometrial cancer. Int J Radiat Oncol Biol Phys.
63:500–504. 2005.
|
|
6
|
Jhingran A, Burke TW and Eifel PJ:
Definitive radiotherapy for patients with isolated vaginal
recurrence of endometrial carcinoma after hysterectomy. Int J
Radiat Oncol Biol Phys. 56:1366–1372. 2003.
|
|
7
|
Jereczek-Fossa B, Badizo A and Jassem J:
Recurrent endometrial cancer after surgery alone: results of
salvage radiotherapy. Int J Radiat Oncol Biol Phys. 48:405–413.
2000.
|
|
8
|
Sorbe B, Horvath G, Andersson H, Boman K,
Lundgren C and Pettersson B: External pelvic and vaginal
irradiation versus vaginal irradiation alone as postoperative
therapy in medium-risk endometrial carcinoma - a prospective
randomized study. Int J Radiat Oncol Biol Phys. 82:1249–1255.
2012.
|
|
9
|
Sorbe B, Wolmesjö E and Frankendal B:
VM-26-vincristine-cisplatin combination chemotherapy in the
treatment of primary advanced and recurrent endometrial carcinoma.
Obstet Gynecol. 73:343–348. 1989.
|
|
10
|
Morrow CP, Bundy BN, Kurman RJ, Creasman
WT, Heller P, Homesley HD and Graham JE: Relationship between
surgical-pathological risk factors and outcome in clinical stage I
and II carcinoma of the endometrium: a Gynecologic Oncology Group
Study. Gynecol Oncol. 40:55–65. 1991.
|
|
11
|
Creasman WT, Odicino F, Maisonneuve P,
Quinn MA, Beller U, Benedet JL, et al: Carcinoma of the corpus
uteri, FIGO 26th Annual Report on the Results of Treatment in
Gynecological Cancer. Int J Gynaecol Obstet. 95(Suppl 1):
S105–S143. 2006.
|
|
12
|
Ng TY, Perrin LC, Nicklin JL, Cheuk R and
Crandon AJ: Local recurrence in high-risk node-negative stage I
endometrial carcinoma treated with postoperative vaginal vault
brachytherapy. Gynecol Oncol. 79:490–494. 2000.
|
|
13
|
Hasbini A, Haie-Meder C, Morice P, Chirat
E, Duvillard P, Lhommé C, Delapierre M and Gerbaulet A: Outcome
after salvage radiotherapy (brachytherapy +/− external) in patients
with a vaginal recurrence from endometrial carcinomas. Radiother
Oncol. 65:23–28. 2002.
|
|
14
|
Pai HH, Souhami L, Clark BG and Roman T:
Isolated vaginal recurrences in endometrial carcinoma: treatment
results using high-dose-rate intracavitary brachytherapy and
external beam radiotherapy. Gynecol Oncol. 66:300–307. 1997.
|
|
15
|
Petignat P, Jolicoeur M, Alobaid A, Drouin
P, Gauthier P, Provencher D, Donath D and Van Nguyen T: Salvage
treatment with high-dose-rate brachytherapy for isolated vaginal
endometrial cancer recurrence. Gynecol Oncol. 101:445–449.
2006.
|
|
16
|
Hart KB, Han I, Shamsa F, Court WS, Chuba
P, Deppe G, Malone J, Christensen C and Porter AT: Radiation
therapy for endometrial cancer in patients treated for
postoperative recurrence. Int J Radiat Oncol Biol Phys. 41:7–11.
1998.
|
|
17
|
Corn BW, Lanciano RM, D’agostino R,
Kiggundu E, Dunton CJ, Purser P and Greven KM: The relationship of
local and distant failure from endometrial cancer: defining a
clinical paradigm. Gynecol Oncol. 66:411–416. 1997.
|
|
18
|
Wylie J, Irwin C, Pintilie M, Levin W,
Manchul L, Milosevic M and Fyles A: Results of radical radiotherapy
for recurrent endometrial cancer. Gynecol Oncol. 77:66–72.
2000.
|
|
19
|
Colombo A, Cormio G, Placa F, Landoni F,
Ardizzoia A, Gabriele A and Lissoni A: Brachytherapy for isolated
vaginal recurrences from endometrial carcinoma. Tumori. 84:649–651.
1998.
|
|
20
|
Blecharz P, Brandys P, Urbański K,
Reinfuss M and Patla A: Vaginal and pelvic recurrences in stage I
and II endometrial carcinoma - survival and prognostic factors. Eur
J Gynaecol Oncol. 32:403–407. 2011.
|
|
21
|
Smaniotto D, D’Agostino G, Luzi S,
Valentini V, Macchia G, Mangiacotti MG, Margariti PA, Ferrandina G
and Scambia G: Concurrent 5-fluorouracil, mitomycin C and
radiation, with or without brachytherapy, in recurrent endometrial
cancer: a scoring system to predict clinical response and outcome.
Tumori. 91:215–220. 2005.
|
|
22
|
Sorbe B and Söderström K: Treatment of
vaginal recurrences in endometrial carcinoma by high-dose-rate
brachytherapy. Anticancer Res. 33:241–247. 2013.
|
|
23
|
Nag S, Yacoub S, Copeland LJ and Fowler
JM: Interstitial brachytherapy for salvage treatment of vaginal
recurrences in previously unirradiated endometrial cancer patients.
Int J Radiat Oncol Biol Phys. 54:1153–1159. 2002.
|
